MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol

Despite progress in the treatment of head and neck squamous cell carcinoma (HNSCC) in recent decades, including new surgical techniques, radiotherapy advances and chemotherapy schedules, the prognosis for the affected patients has not improved at the same pace, and still, most HNSCC patients are dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Arantes, Lidia Maria Rebolho Batista, Laus, Ana Carolina, Melendez, Matias Eliseo, de Carvalho, Ana Carolina, Sorroche, Bruna Pereira, De Marchi, Pedro Rafael Martins, Evangelista, Adriane Feijó, Scapulatempo-Neto, Cristovam, de Souza Viana, Luciano, Carvalho, André Lopes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354780/
https://www.ncbi.nlm.nih.gov/pubmed/28039483
http://dx.doi.org/10.18632/oncotarget.14253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354780/
https://www.ncbi.nlm.nih.gov/pubmed/28039483
http://dx.doi.org/10.18632/oncotarget.14253

Ejemplares similares